Related Experiment Video
Updated: Aug 13, 2026
08:17
Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
Published on: September 27, 2018
Gastric electrical stimulation: a report of two cases
V Sibartie1, E M M Quigley, A O'Donnell
1Alimentary Pharmabiotic Centre, Department of Medicine, Cork University Hospital, Wilton. vsibartie@hotmail.com
Irish Medical Journal
|February 1, 2006
Summary
Gastric electrical stimulation (GES) offers a new treatment for severe gastroparesis. Early results in Ireland show reduced symptoms and improved quality of life for patients unresponsive to medication.
Area of Science:
- Gastroenterology
- Medical Devices
- Neuromodulation
Background:
- Gastroparesis refractory to prokinetic agents presents a significant clinical challenge.
- Gastric electrical stimulation (GES) is an emerging electrical therapy for gastroparesis.
- GES has shown promise in animal and human studies, gaining traction in specialized centers globally.
Observation:
- This report details the first two gastric neurostimulator implantations in Ireland.
- The study focuses on the outcomes for these two patients receiving GES.
- The procedures were performed in a clinical gastroenterology setting.
Findings:
- Six-month follow-up revealed a notable reduction in gastroparesis symptoms.
- Patients experienced a significant improvement in their quality of life.
- These outcomes are encouraging for the studied cohort.
Implications:
- GES demonstrates potential as a valuable tool for refractory gastroparesis.
- Further evaluation of GES is warranted for patients failing medical therapy.
- This study highlights the successful introduction of GES in a new geographical region.
